These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 19571801)

  • 1. Transporters for drug delivery and as drug targets in parasitic protozoa.
    Landfear SM
    Clin Pharmacol Ther; 2010 Jan; 87(1):122-5. PubMed ID: 19571801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery strategies for antiparasitics.
    Kayser O; Kiderlen AF
    Expert Opin Investig Drugs; 2003 Feb; 12(2):197-207. PubMed ID: 12556214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From chemical graphs in computer-aided drug design to general Markov-Galvez indices of drug-target, proteome, drug-parasitic disease, technological, and social-legal networks.
    Riera-Fernández P; Munteanu CR; Dorado J; Martin-Romalde R; Duardo-Sanchez A; González-Diaz H
    Curr Comput Aided Drug Des; 2011 Dec; 7(4):315-37. PubMed ID: 22050683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Polyamines in Parasite Cell Architecture and Function.
    Vannier-Santos MA; Suarez-Fontes AM
    Curr Pharm Des; 2017; 23(23):3342-3358. PubMed ID: 28671059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and metabolic peculiarities of some parasites availing as targets for therapy.
    Frayha GJ; Gobert JG; Savel J
    J Med Liban; 2001; 49(4):210-27. PubMed ID: 12412970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria as a promising antiparasitic target.
    Monzote L; Gille L
    Curr Clin Pharmacol; 2010 Feb; 5(1):55-60. PubMed ID: 20236083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heme metabolism as a therapeutic target against protozoan parasites.
    Lechuga GC; Pereira MCS; Bourguignon SC
    J Drug Target; 2019 Aug; 27(7):767-779. PubMed ID: 30332897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinases as targets for antiparasitic chemotherapy drugs.
    Canduri F; Perez PC; Caceres RA; de Azevedo WF
    Curr Drug Targets; 2007 Mar; 8(3):389-98. PubMed ID: 17348832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apicomplexa, trypanosoma and parasitic nematode protein kinases as antiparasitic therapeutic targets.
    Liotta F; Siekierka JJ
    Curr Opin Investig Drugs; 2010 Feb; 11(2):147-56. PubMed ID: 20112164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and biopharmaceutical issues in the development of drug delivery systems for antiparasitic drugs.
    Kayser O; Olbrich C; Croft SL; Kiderlen AF
    Parasitol Res; 2003 Jun; 90 Suppl 2():S63-70. PubMed ID: 12937968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parasitic infections and myositis.
    El-Beshbishi SN; Ahmed NN; Mostafa SH; El-Ganainy GA
    Parasitol Res; 2012 Jan; 110(1):1-18. PubMed ID: 21881948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aromatic diamidines as antiparasitic agents.
    Soeiro MN; De Souza EM; Stephens CE; Boykin DW
    Expert Opin Investig Drugs; 2005 Aug; 14(8):957-72. PubMed ID: 16050790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosynthetic pathways of plastid-derived organelles as potential drug targets against parasitic apicomplexa.
    Seeber F
    Curr Drug Targets Immune Endocr Metabol Disord; 2003 Jun; 3(2):99-109. PubMed ID: 12769782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomaterials as a Potential Target for Infectious Parasitic Agents.
    Alsharedeh RH; Rezigue M; Bashatwah RM; Amawi H; Aljabali AAA; Obeid MA; Tambuwala MM
    Curr Drug Deliv; 2024; 21(6):828-851. PubMed ID: 36815647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Inhibitors as Antiparasitic Drugs: Pharmacological, Biochemical and Molecular Perspectives.
    Mukherjee S; Mukherjee N; Gayen P; Roy P; Babu SP
    Curr Drug Metab; 2016; 17(10):937-970. PubMed ID: 27719626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding Bromodomain Targeting into Neglected Parasitic Diseases.
    Tallant C; Bamborough P; Chung CW; Gamo FJ; Kirkpatrick R; Larminie C; Martín J; Prinjha R; Rioja I; Simola DF; Gabarró R; Calderón F
    ACS Infect Dis; 2021 Nov; 7(11):2953-2958. PubMed ID: 34612618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles.
    Date AA; Joshi MD; Patravale VB
    Adv Drug Deliv Rev; 2007 Jul; 59(6):505-21. PubMed ID: 17574295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential chemotherapeutic targets in the purine metabolism of parasites.
    el Kouni MH
    Pharmacol Ther; 2003 Sep; 99(3):283-309. PubMed ID: 12951162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parasitic Protozoa: Unusual Roles for G-Quadruplexes in Early-Diverging Eukaryotes.
    Dumetz F; Merrick CJ
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30959737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parasite Cathepsin D-Like Peptidases and Their Relevance as Therapeutic Targets.
    Sojka D; Hartmann D; Bartošová-Sojková P; Dvořák J
    Trends Parasitol; 2016 Sep; 32(9):708-723. PubMed ID: 27344362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.